INPLASY202350006

Efficacy and Safety of Chemo-Immunotherapy Regimes for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Network Meta-Analysis and Cost-Effectiveness Analysis

Keywords: recurrent or metastatic nasopharyngeal carcinoma; toripalimab; camrelizumab; tislelizumab; gemcitabine and cisplatin; chemo-immunotherapy; cost-effectiveness.

Download PDF - 202350006

Review Status: Ongoing